(Q36777965)

16 August 2017

1 reference

title

Toenail onychomycosis: current and future treatment options (English)

1 reference

16 August 2017

2

Erin M Warshaw

1 reference

16 August 2017

Justin J Finch

1

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

20

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

31-46

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

16 August 2017

1 reference

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Risk factors associated with onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Effect of onychomycosis on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Onychomycosis: a significant medical disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Quality of life of persons with onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Onychomycosis. Baseline results of an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Facing up to the diagnostic uncertainty and management of onychomycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Traditional management of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Terbinafine in onychomycosis of the toenail: A novel treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Terbinafine-induced hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Tioconazole nail solution--an open study of its efficacy in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Evaluating costs for onychomycosis treatments: a practitioner's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Onychomycosis in children: treatment with bifonazole-urea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Topical treatment of onychomycosis using bifonazole 1% urea/40% paste

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Treatment of onychomycosis with nail avulsion and topical ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Topical and oral combination therapy for toenail onychomycosis: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Itraconazole pulse therapy for the treatment of Candida onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Treatment of Candida nail infection with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Long-term results in patients with onychomycosis treated with terbinafine or itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

Combination therapy for onychomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

An Overview of Topical Antifungal Therapy in Dermatomycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2007.00109.X

10.1111/J.1529-8019.2007.00109.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference